Summary of Cardinal Health, Inc. Conference Call Company Overview - **Company**: Cardinal Health, Inc. (NYSE: CAH) - **Industry**: Healthcare Services - **Participants**: Jason Hollar (CEO), Aaron Alt (CFO), Lisa Gill (J.P. Morgan Managing Director) Key Points and Arguments Company Profile - Cardinal Health serves 90% of U.S. hospitals, 20,000 specialty physicians, and 5 million home patients, with a projected revenue of over $225 billion for fiscal 2024 [4][5] - The company operates globally in 30 countries with nearly 50,000 employees [4] Financial Performance - The pharmaceutical segment is the largest, projected to generate nearly $190 billion in revenue, contributing approximately $2 billion in profit for the last year [5][9] - The medical segment has faced challenges due to inflation but is undergoing a turnaround with a focus on an improvement plan [6][9] - Cardinal Health has returned over $3.3 billion to shareholders through dividends and share repurchases, with $750 million planned for fiscal 2024 [9] Strategic Initiatives - The company has completed a business and portfolio review, focusing on growth businesses: at-Home Solutions and OptiFreight logistics [10][11] - Cardinal Health has restructured its organization to align with growth initiatives, maintaining a focus on simplification and core business [11][13] - Long-term EPS growth targets remain unchanged at 12% to 14% [17][20] Growth Segments - **At-Home Solutions**: Grew from $1 billion to $2.6 billion over ten years, serving 5 million patients with 99% coverage [27] - **Nuclear and Precision Health**: Offers high-touch distribution services, reaching 95% of hospitals within three hours [28][29] - **OptiFreight Logistics**: Provides $700 million in savings for customers through freight management [30] Market Dynamics - The pharmaceutical segment is benefiting from strong underlying growth, with expectations for over 20% EPS growth in fiscal 2024 [9][44] - The company anticipates normalization in growth rates for GLP-1s, which have contributed to recent revenue spikes [44][46] Challenges and Opportunities - The medical segment is still working on mitigating inflation impacts, with a goal to achieve 70% mitigation by the end of fiscal 2024 [25] - Cardinal Health is open to M&A opportunities in growth areas, including nuclear, at-Home Solutions, and OptiFreight logistics [32][33] Governance and Accountability - The company has appointed four new independent directors and formed a business review committee to enhance governance [10] - The restructuring aims to provide transparency and accountability for growth businesses [39][40] Future Outlook - Cardinal Health aims to continue strong cash flow generation and responsible capital allocation to create shareholder value [35] - The focus will remain on organic growth and investment in specialty pharmaceuticals and medical improvement plans [22][23] Additional Important Insights - The company is committed to supporting independent pharmacies and enhancing their competitiveness [69] - Cardinal Health emphasizes the importance of innovation and customer relationships in driving future growth [56][66] This summary encapsulates the key points discussed during the conference call, highlighting Cardinal Health's strategic direction, financial performance, and growth opportunities within the healthcare industry.

Cardinal Health, Inc. (NYSE:CAH) J.P. Morgan 42nd Annual Healthcare Conference January 9, 2024 5:15 PM ET Company Participants Lisa Gill - Managing Director at JPMorgan Conference Call Participants Jason Hollar - CEO Aaron Alt - CFO Lisa Gill Good afternoon and thank you for joining us. My name is Lisa Gill and I head the Healthcare Services Group here at J.P. Morgan. With me this afternoon is Cardinal Health. Presenting for Cardinal will be CEO, Jason Hollar. After Jason's presentation, he will join me and ...

Shares of Cardinal Health Inc. CAH, -0.52% rallied 1.7% in premarket trading Tuesday, after the drug distributor said it expects fiscal 2024 earnings to be at the high-end of previous guidance. The stock was on track to open at the highest price seen since it closed at a record $108.05 on Dec. 13. The company added that while a review of its businesses remains “active and ongoing,” it has already determined that it would further develop its growth businesses in its Medical Segment, at-Home Solutions and Op ...

Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and OptiFreight® Logistics as part of the company's portfolio for long-term growth and value creation Review of Global Medical Products and Distribution business continues, with focus on driving operational performance through the Medical Improvement Plan Reorganizing leadership structure to continue company's simplifi ...

Major U.S. stock indices witnessed turmoil on Jan 5, ending with a marginal rise. This was most likely due to mixed sentiments among investors about the latest macroeconomic data, which offered conflicting perspectives on the timing of potential interest rate cuts.In such a situation, an investor might not feel confident enough to invest in the stock market. However, a prudent investor knows that this is the right time to buy stocks that are safe bets. To this end, we recommend stocks like Live Oak Bancshar ...

DUBLIN, Ohio, Jan. 2, 2024  /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on t ...

Cardinal Health, Inc. (NYSE:CAH) Q1 2024 Earnings Conference Call November 3, 2023 8:30 AM ET Company Participants Matt Sims - VP of IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Lisa Gill - JPMorgan Eric Percher - Nephron Research Kevin Caliendo - UBS Erin Wright - Morgan Stanley George Hill - Deutsche Bank Elizabeth Anderson - Evercore Daniel Grosslight - Citi Charles Rhyee - TD Cowen Allen Lutz - Bank of America Operator Good day, and welcome to today's First Quarter Financial Year 2 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 1-11373 Cardinal Health, Inc. (Exact name of registrant as specified in its charter) (State or other j ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_0dfd0b29486237e1091cb07603273918.html ...

Q4 FY23 Earnings Cardinal Health, Inc. August 15, 2023 ...